Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
EDITOR,--J E Charlton draws attention to the estimated overall death rate of 1 in 2000 from upper gastrointestinal endoscopy, which is usually performed under sedation or local anaesthesia, or both.1 When compared with the overall mortality solely attributable to anaesthesia, which is 1 in 185000,2 this mortality seems unacceptably high.
Recommendations for standards of sedation and for monitoring patients during gastrointestinal endoscopy were published by the British Society of Gastroenterology in 1991,3 and guidelines for sedation by non-anaesthetists were published by a working party of the Royal College of Surgeons in 1993.4 Despite this, practice across Britain seems to vary widely.
We were surprised to find that in some regions the preferred benzodiazepine for sedation during endoscopy is diazepam,5 which has an active principal metabolite (desmethyldiazepam) with a half life of 48-96 hours. Midazolam has been recommended as the drug of choice for
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?